04-8764. Office of Research and Development; Government Owned Invention Available for Licensing  

  • Start Preamble

    AGENCY:

    Office of Research and Development, Department of Veterans Affairs.

    ACTION:

    Notice of government owned invention available for licensing.

    SUMMARY:

    The invention listed below is owned by the U.S. Government as represented by the Department of Veterans Affairs, and is available for licensing in accordance with 35 U.S.C. 207 and 37 CFR part 404 and/or CRADA Collaboration under 15 U.S.C. 3710a to achieve expeditious commercialization of results of federally funded research and development. Foreign patents are filed on selected inventions to extend market coverage for U.S. companies and may also be available for licensing.

    Start Further Info

    FOR FURTHER INFORMATION CONTACT:

    Technical and licensing information on the invention may be obtained by writing to: Robert W. Potts, Department of Veterans Affairs, Director Technology Transfer Program, Office of Research and Development (12TT), 810 Vermont Avenue, NW., Washington, DC 20420; fax: (202) 254-0473; e-mail at bob.potts@hq.med.va.gov. Any request for information should include the Number and Title for the relevant invention as indicated below. Issued patents may be obtained from the Commissioner of Patents, U.S. Patent and Trademark Office, Washington, DC 20231.

    End Further Info End Preamble Start Supplemental Information

    SUPPLEMENTARY INFORMATION:

    The invention available for licensing is: U.S. Provisional Patent Application No. 60/518,304 “Chronic Lymphocytic Leukemia Treatment”.

    Start Signature

    Dated: April 7, 2004.

    Anthony J. Principi,

    Secretary, Department of Veterans Affairs.

    End Signature End Supplemental Information

    [FR Doc. 04-8764 Filed 4-16-04; 8:45 am]

    BILLING CODE 8320-01-P

Document Information

Published:
04/19/2004
Department:
Veterans Affairs Department
Entry Type:
Notice
Action:
Notice of government owned invention available for licensing.
Document Number:
04-8764
Pages:
20965-20965 (1 pages)
PDF File:
04-8764.pdf